97% of the World's Humanoid Robots Are Now Made in China: A Three-Year Timeline of Total Domination

heroImage: "https://images.unsplash.com/photo-1546776310-eef45dd6d63c?w=1200"

*Photo: The assembly line that ate the world — Chinese humanoid robots rolling off production lines at a pace no other country has matched. In H1 2026, China shipped 97% of all humanoid robots sold globally. Image: Unsplash*

In August 2026, the second World Humanoid Robot Games opened in Beijing with a spectacle that would have been unthinkable three years earlier. Five hundred humanoid robots from 16 countries and 280 teams competed across 26 events — sprinting, playing football, dancing in formation, boxing, and navigating obstacle courses. The stands were packed. The medal count was not close.

China's robots won more than half the gold medals. They also, by that point, had already won something far more consequential: the global market itself.

The numbers behind the first half of 2026 tell a story of industrial dominance that has few precedents in modern manufacturing history. Of the roughly 19,600 humanoid robots shipped worldwide between January and June, approximately 19,000 — or 97% — came from Chinese factories. That figure comes from Smart Analytics Global, a robotics research firm, and it represents a threshold crossing: humanoid robots, the technology that Silicon Valley has spent years promising and not yet delivering at scale, have quietly become a Chinese export industry.

To understand how this happened, you have to trace the arc. Not a slow build-up over decades, but a violent, three-year acceleration driven by price collapse, supply chain mastery, and a manufacturing ecosystem that no other country can currently replicate.

The Snapshot: H1 2026 in Numbers

Before the timeline, the current state. The H1 2026 shipment data reveals a market that has not just grown — it has consolidated.

The most striking detail is not the growth rate, though 300% year-over-year is extraordinary. It is the leadership change. For two years, Unitree Robotics was the undisputed volume king — the company that made the $1,600 robot dog, the $16,000 humanoid, and the viral Spring Festival Gala performances. In H1 2026, AgiBot passed it. The reasons why tell you almost everything about where this industry is heading.

Phase 1: The Demonstration Era (2022–2023)

In October 2022, Tesla held its AI Day presentation and showed the world Optimus — a prototype humanoid robot that walked stiffly on stage, waved, and was famously derided as "a guy in a suit" in its earliest form. The robotics establishment was skeptical. The engineering challenges of bipedal locomotion, dexterous manipulation, and real-world reliability had defeated decades of well-funded attempts.

In China, a different conversation was happening. Not in research labs, but in industrial parks.

The question Chinese engineers asked was not "can we make a humanoid robot walk?" It was "how cheaply can we make one that works well enough to be useful?" That framing difference — engineering-for-cost rather than engineering-for-demos — would prove decisive.

Unitree, founded in 2016 by Wang Xingxing in Hangzhou, had already proven the model with quadruped robots. Its Go1 robot dog launched at $2,700 in 2021, undercutting Boston Dynamics' Spot by a factor of 30. By 2022, Unitree was profitable on robot dog sales alone — a feat no Western robotics company had achieved.

In Shanghai, AgiBot (Zhiyuan Robotics) was founded in early 2023 by Peng Zhihui, the former Huawei "genius youth" whose viral engineering videos had made him one of China's most-watched technologists. AgiBot's pitch was different from Unitree's: not the cheapest robot, but the most capable general-purpose platform, designed from day one for mass production.

By the end of 2023, China had perhaps a dozen serious humanoid robot companies. The United States had Figure AI (founded 2022), Agility Robotics (spun out of Oregon State in 2015), Boston Dynamics (owned by Hyundai), Tesla, and 1X Technologies. The count was roughly even. The trajectories were not.

Phase 2: The Price Collapse (2024–Early 2025)

The event that changed everything was not a product launch. It was a price announcement.

In May 2024, Unitree unveiled the G1 humanoid at $16,000. The robotics world did a double-take. Comparable research-grade humanoid platforms from Western manufacturers cost $150,000 to $500,000. Tesla had suggested Optimus might eventually cost $20,000, but "eventually" was doing a lot of work in that sentence. Unitree was selling a shipping product at that price *today*.

Then, in July 2025, Unitree did it again. The R1 — a 121-centimeter humanoid with 26 degrees of freedom — launched at $4,900. Four thousand nine hundred dollars. That is less than a MacBook Pro. The R1 was not a toy; it was a fully programmable research platform with the same fundamental locomotion stack as Unitree's larger machines.

The pricing strategy was not charity. It was the Shenzhen playbook applied to a new category: capture volume early, drive costs down through scale, own the supply chain, and let the software ecosystem build on your hardware. Unitree had executed it with robot dogs. Now it was executing it with humanoids.

By early 2025, the entire humanoid robot supply chain — actuators, harmonic reducers, torque sensors, dexterous hands, joint modules — was clustering in the Yangtze River Delta and Pearl River Delta regions. The same industrial ecosystem that made China the world leader in drones, electric vehicles, and lithium batteries was now doing the same for robots. A component that cost $2,000 from a European supplier could be sourced for $200 from a factory in Suzhou.

The gap was no longer about engineering talent. It was about manufacturing depth. And that is not a gap that closes quickly.

Phase 3: The Production Explosion (2025–Mid 2026)

The numbers from this phase read like a hockey stick that broke the chart.

In 2025, global humanoid shipments were approximately 13,000 units — up 235% from the year before, but still modest. The inflection came in early 2026. AgiBot hit its 10,000th cumulative robot in March 2026, having scaled production from 1,000 units to 5,000 to 10,000 in roughly three months. Unitree's Shenzhen factory ramped toward annual capacity of 75,000 humanoid units.

Then came the first half of 2026.

Counterpoint Research's data shows over 22,000 humanoids shipped globally — a 300% year-over-year surge. Smart Analytics Global's more conservative count puts it at 19,600. Either way, the geographic breakdown is the story: China accounted for approximately 97% of all units.

The "~600 non-China" figure deserves emphasis. In the first half of 2026, the entire rest of the world — the United States, Japan, South Korea, Europe — combined to ship approximately 600 humanoid robots. AgiBot alone shipped 16 times that number.

Tesla's Optimus, the robot that sparked the modern humanoid race, remained in internal deployment at Tesla factories. Figure AI's Figure 03, backed by more than $2.6 billion in funding and partnered with BMW, was in pilot programs but not commercially available. Agility Robotics' Digit was in early commercial deployments but at volumes measured in the dozens. Boston Dynamics' new electric Atlas had just begun commercial deployment.

The Western humanoid industry was, in effect, still in the demonstration era. China had moved on to the manufacturing era.

Phase 4: The Capital Wave (2026)

Manufacturing dominance attracts capital. In 2026, the capital arrived in waves.

The landmark event was Unitree's IPO on the Shanghai STAR Market. Priced in early August at a $9 billion valuation, the stock surged on debut — closing up between 460% and 629% depending on the trading day measured, briefly valuing the company above $61 billion. For a company that had been profitable since 2022 and grew revenue 68% in Q1 2026 (even as profit dipped 53% due to aggressive capacity expansion), the market was pricing in a future where Unitree becomes the Foxconn of humanoid robots.

The IPO prospectus revealed numbers that startled even industry watchers. In 2025, humanoid robot revenue surpassed quadruped revenue for the first time, accounting for more than 51% of total sales. Combined gross margin across both segments reached 60% — demolishing the assumption that robotics is a capital-incinerating business that only survives on venture funding.

The pattern is clear. Chinese robotics companies are generating revenue, achieving profitability, and going public. Western humanoid companies are raising venture capital and running pilot programs. Both are valid strategies. Only one of them currently produces robots at scale.

Morgan Stanley has doubled its China humanoid shipment forecast in response, now projecting the country will deliver the lion's share of 50,000–60,000 global units in full-year 2026. TrendForce projects China's humanoid output will grow 94% this year, with Unitree and AgiBot capturing nearly 80% of total shipments between them.

The Supply Chain Moat

Why can't anyone else replicate this? The answer is not one thing. It is hundreds of things, each individually boring, collectively decisive.

A humanoid robot contains between 30 and 60 actuated joints, each requiring precision motors, harmonic reducers, torque sensors, and controllers. It needs a battery system, structural components, thermal management, cameras, LiDAR or depth sensors, and a computing stack. It needs dexterous hands — each one a marvel of miniature engineering with 10 to 20 independently actuated degrees of freedom.

In Shenzhen and Suzhou, every one of those components has multiple domestic suppliers competing on price and quality. The Suzhou Harmonic Drive facility has scaled production of precision reducers. Midea's KUKA subsidiary and a dozen smaller firms produce robot joint modules. Battery suppliers like CATL, which already dominates global EV battery production, supply optimized cells for robotics applications.

This is the same moat that made DJI dominant in drones, and that made China's EV industry the largest in the world. Once the supply chain localizes, the cost advantage compounds. A Western humanoid startup sourcing components from European and American suppliers pays 3–5 times more for the same bill of materials — before accounting for lead times that can stretch to six months.

China's Ministry of Industry and Information Technology has proposed more than 100 national standards for humanoid robots by 2028, covering everything from safety requirements to interoperability protocols. Each robot unit is expected to carry a 29-digit digital ID for traceability. The government is not just permitting the humanoid industry — it is building the regulatory and standardization infrastructure to lock in first-mover advantage.

The Geopolitical Shadow

There is a darker side to this story, and it would be incomplete to omit it.

On June 10, 2026, the U.S. Department of Defense added 65 Chinese companies to its Section 1260H list of entities with alleged military connections. Unitree was added to the list. AgiBot was not — a distinction that has drawn attention given AgiBot's dominant market position and its push toward a Hong Kong listing.

On July 28, 2026, the FCC moved to ban U.S. imports of new humanoid and quadruped robots from China, citing national security concerns. The ban targets new products, meaning existing inventory can still be sold, but the signal is unmistakable: the United States views Chinese robotics dominance as a strategic vulnerability, and it is beginning to wall off its market.

The commercial impact is real but bounded. The U.S. represents a significant portion of global robotics demand, but it is not the majority. Unitree and AgiBot are both expanding aggressively in Southeast Asia, the Middle East, Europe, and Latin America — regions with no import restrictions and strong demand for affordable automation. AgiBot showcased its full product line at CES 2026 in Las Vegas and IFA 2026 in Berlin. The company is positioning itself as a global supplier, not a domestic one.

The longer-term risk for Western markets is not security — it is relevance. If the humanoid robot market develops the way the drone market did, where DJI captured 70%+ global share and never gave it back, then the countries that restrict Chinese robots today may find themselves locked out of the defining automation technology of the 2030s.

What Comes Next

The rest of 2026 will determine whether China's humanoid dominance is a durable structural advantage or a head start that competitors can close.

Three variables matter most.

Tesla Optimus Gen 3. If Tesla reaches mass production as scheduled in the second half of 2026, it could reset the competitive landscape. Tesla has the AI stack, the manufacturing experience, and the capital. What it does not yet have is a shipping product. Every quarter that passes without Optimus on the market is a quarter where Chinese vendors deepen their lead and their supply chain moat.

The application shift. In the second half of 2026, the industry's focus is shifting from foundational capabilities — walking, balancing, grasping — toward delivering measurable user value. This is where deployment scale becomes a self-reinforcing advantage. A robot that has worked in 500 factories has training data that a lab demo cannot replicate. China's installed base gives it a data flywheel that Western competitors cannot match without first shipping robots, which they cannot do at competitive prices without the supply chain, which is in China.

Unit economics under pressure. Unitree's Q1 2026 results revealed the cost of aggressive expansion: profit fell 53% even as revenue surged 68%. The company is investing ahead of demand, building capacity for a market that has not fully materialized. If the demand materializes — and 50,000+ global shipments in 2026 would suggest it is — Unitree's bet pays off handsomely. If not, the entire sector faces a correction.

The most likely scenario, based on everything the data tells us, is not a correction but a consolidation. The 150+ Chinese humanoid companies will compress to perhaps 10 that matter globally. AgiBot and Unitree will continue to dominate volume. The price floor will keep falling — the R1 at $4,900 is not the end, and a $2,000 humanoid is plausible by 2027. And the rest of the world will face a choice it has faced before with solar panels, batteries, and EVs: build domestic capacity at higher cost, or buy from China.

The second World Humanoid Robot Games gave us a preview. The robots that won medals were Chinese. The robots that won market share were Chinese. And the robots that will define the next decade of physical AI are, increasingly, made in China.

The demonstration era is over. The manufacturing era has begun. And 97% is not a statistic — it is a statement of industrial fact.

Social Media Reactions

微博 / Weibo:

智元超越宇树成为上半年人形机器人出货第一，这个结果很多人没想到。但仔细想想也不意外——智元从第一天就想着量产，不是做Demo。这才叫真正的产品思维。 [AgiBot overtaking Unitree as H1's top humanoid shipper surprised many. But it makes sense — AgiBot was designed for mass production from day one, not for demos. That is real product thinking.]

97%的全球份额，这意味着什么？意味着当美国还在讨论人形机器人安不安全的时候，中国的机器人已经在工厂里干活了。不是技术差距，是执行力差距。 [97% global share means what? It means while America debates whether humanoid robots are safe, China's robots are already working in factories. Not a technology gap — an execution gap.]

X / Twitter:

The FCC banned Chinese humanoid robot imports in July. Unitree still IPO'd at $61B. The ban doesn't matter because the US is only one market. Southeast Asia, Middle East, Europe are all buying. The wall is porous and the robots are cheap.

Hacker News:

I work in warehouse automation. We evaluated Figure, Agility, and Unitree last quarter. Unitree G1 was 10x cheaper than Digit and we could get 50 units in 3 weeks. Figure doesn't even sell theirs. The "Chinese dominance" headline understates it — for buyers, there's only one real option today.

Reddit r/robotics:

Everyone talks about Tesla Optimus like it's the benchmark. But Unitree shipped 6,300 robots in 6 months at prices anyone can afford. Tesla shipped zero that you can buy. At some point we need to admit the "demo vs product" distinction matters more than the AI benchmarks.

*Research and analysis by the AI in China editorial team. Data sources: Counterpoint Research, Smart Analytics Global, TrendForce, Morgan Stanley, Forbes, SCMP, CNBC, TrendForce press releases. All market data as of H1 2026 reporting.*